As CRISPR genome editing struggles to overcome key specificity and delivery challenges in its pursuit to realize therapeutic applications, the 2nd RNA Editing Summit returns to help you accelerate the translation and commercialization of RNA editing for an array of research and therapeutic applications.
This virtual conference focuses specifically on the latest approaches in RNA-editing systems and the targeting molecules used to direct these agents to sites of interest.
Join RNA, functional genomic and cell biology experts from large pharma, biotech and academia to address core challenges, including:
- Mitigating against off-targeting editing
- Determining pharmacodynamics/pharmacokinetics to inform dosing
- Identifying the right chemical modifications of editing oligonucleotides to increase specificity and stability
- Preventing immunogenicity of different delivery mechanisms
Be part of the online interactive discussions from the comfort of your home or office to bring the therapeutic potential of RNA editing to rare diseases, oncology, ophthalmic disorders, cardiovascular disease and many more to a commercial reality.
'The field of RNA editing has been exploding the last couple of years, and this inaugural RNA editing summit is going to be a great place for people to hear the science about RNA editors, as well as the different approaches to utilize or inhibit these enzymes for the treatment of human diseases.'
Scott Ribich - Vice President, Biology,
'RNA editing expands the evolutionary landscape by increasing the diversity of gene products and enhances the therapeutic universe by enabling interventions that go beyond what is possible in a world focused solely on rewriting DNA sequence. This meeting will help expand the collaborations and toolsets for this new era of innovation.'
Alan Herbert - Founder & Head of Discovery,